Rival Gilles, Chalbet Sophie, Dupont Clarisse, Brun Philippe, Letranchant Lorraine, Reynaud Claire, Dureault Aurélie, Saison Julien, Jeannot Mathieu, Barbour Sophie, Bacconnier Michaël, Paulus Valérie, Champagne Hélène, Buiret Guillaume
Pneumology Department, Valence Hospital Center, Valence, France.
Infectious Diseases Department, Valence Hospital Center, Valence, France.
Can J Respir Ther. 2023 Jan 20;59:20-25. doi: 10.29390/cjrt-2022-017. eCollection 2023.
The coronavirus Severe Acute Respiratory Syndrome Coronavirus Type 1 induces a severe respiratory disease, coronavirus disease 2019 (COVID-19). After Severe Acute Respiratory Syndrome Coronavirus Type 1 and Middle East Respiratory Syndrome infection, increased post-traumatic stress disorder (PTSD) rates were described.
This single-centred, prospective study aimed to evaluate the rates of PTSD in patients who were hospitalized for COVID-19. Inclusion criteria were COVID-19 patients hospitalized in the intensive care unit (ICU) or in a standard unit with at least 2 L/min oxygen. Six months post-hospitalization, subjects were assessed for PTSD using a validated screening tool, the Post-Traumatic Stress Checklist-5 (PCL-5).
A total of 40 patients were included. No demographic differences between the ICU and non-ICU groups were found. The mean PCL-5 score for the population was 8.85±10. The mean PCL-5 score was 6.7±8 in the ICU group and 10.5±11 in the non-ICU group (P=0.27). We screened one patient with a positive PCL-5 score and one with a possible PCL-5 cluster score. Nine patients had a PCL-5 score of up to 15. Seven patients reported no symptoms. Seven patients accepted a psychological follow-up: one for PTSD, three for possible PTSD and three for other psychological problems.
The PCL-5 tool can be used by lung physicians during consultations to identify patients for whom follow-up mental health assessment and treatment for PTSD are warranted.
Lung physicians should be aware of the risk of PTSD in patients hospitalized for COVID-19 and ensure appropriate screening and follow-up care.
冠状病毒严重急性呼吸综合征冠状病毒1型可引发一种严重的呼吸道疾病，即2019冠状病毒病（COVID-19）。在严重急性呼吸综合征冠状病毒1型和中东呼吸综合征感染后，创伤后应激障碍（PTSD）的发病率有所上升。
这项单中心前瞻性研究旨在评估因COVID-19住院患者的PTSD发病率。纳入标准为在重症监护病房（ICU）或接受至少2升/分钟氧气治疗的标准病房住院的COVID-19患者。出院六个月后，使用经过验证的筛查工具创伤后应激检查表-5（PCL-5）对受试者进行PTSD评估。
共纳入40例患者。未发现ICU组和非ICU组在人口统计学上存在差异。总体人群的PCL-5平均得分为8.85±10。ICU组的PCL-5平均得分为6.7±8，非ICU组为10.5±11（P = 0.27）。我们筛查出一名PCL-5评分呈阳性的患者和一名可能存在PCL-5聚类评分的患者。9例患者的PCL-5评分高达15。7例患者报告无相关症状。7例患者接受了心理随访：1例为PTSD，3例为可能的PTSD，3例为其他心理问题。
肺部医生在会诊期间可使用PCL-5工具来识别那些有必要进行PTSD心理健康评估和治疗随访的患者。
肺部医生应意识到因COVID-19住院患者存在PTSD风险，并确保进行适当的筛查和后续护理。
